Notable Labs Gets FDA Clearance For Volasertib Phase 2 Study
24 Jul 2024 //
GLOBENEWSWIRE
Notable Labs Outlines PPMP-Enabled AML Trial at AACR 2024
09 Apr 2024 //
GLOBENEWSWIRE
Notable Advances Volasertib Phase 2 Program
22 Feb 2024 //
GLOBENEWSWIRE
Oncoheroes Biosciences & BI sign exclusive licensing agreement for volasertib
16 Sep 2019 //
PR NEWSWIRE